Bringing the fundamentals into focus…
Back to Jazz Pharmaceuticals plc
How Jazz Pharmaceuticals plc stacks up
JAZZ · against 127 other Healthcare companies of similar size
Valuation
72/ 100
Near the top of its peers.
Ranked #25 of 128 · scores higher than 80% of peers
Bars: peers in each 10-point band of the valuation score19 peers with a valuation score of 70–79, including JAZZ · Click a bar to see the companies
Why valuation scores 72?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its free cash flow yield, earnings yield and EBITDA yield, which are stronger than most Healthcare peers.
- more operating profit (EBITDA) for the company's total value: stronger than 84% of peers. EBITDA yield: 5.3% vs peer median 4.0%
- higher earnings for the price paid: stronger than 85% of peers. Earnings yield: 6.3% vs peer median 1.5%
- more free cash flow for the price paid: stronger than 91% of peers. Free cash flow yield: 10.7% vs peer median 0.0%
Metric by metric
Position: dot = JAZZ, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | JAZZ | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 126 reported | 6.4% | 2.7% | 91% | 30% | |
| EBITDA yieldHigher is better · 129 reported | 11.2% | 4.8% | 91% | 50% | |
| Free cash flow yieldHigher is better · 84 reported | 8.8% | 3.0% | 94% | 20% | |
| Book yieldHigher is better · 126 reported | 32.3% | 21.2% | 68% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around JAZZ| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 89.5B HKD (≈$11.5B) | 98 | 67 | |
| 2 | 10.4B USD | 96 | 64 | |
| 3 | 80.2B CNY (≈$11.2B) | 95 | 76 | |
| 3 | 21.5B USD | 95 | 60 | |
| 5 | 11.6B USD | 94 | 58 | |
| 22 | 13.3B USD | 73 | 59 | |
| 22 | 18.5B USD | 73 | 54 | |
| 25 | 1.21T JPY (≈$8.2B) | 72 | 74 | |
| 25 | 10.8B USD | 72 | 54 | |
| 25 | 14.9B USD | 72 | 65 | |
| 28 | 1.17T JPY (≈$8.0B) | 71 | 58 | |
| 28 | 975.0B INR (≈$11.7B) | 71 | 65 | |
| 28 | 14.9B EUR (≈$16.4B) | 71 | 52 | |
| 28 | 10.9B EUR (≈$11.9B) | 71 | 59 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score